ClinicalTrials.gg
Status unknownNCT03514251Updated May 2, 2018

Study on Application of Suturing Parathyroid Markers in Thyroid Cancer Surgery

An interventional study of The suture marks the location of the parathyroid gland in Thyroid Cancer, Hypoparathyroidism and Marker; Structural, sponsored by Bo Wang,MD. Status unknown at 1 site in China. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2018-05-02.

Sponsored by Bo Wang,MD · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Apr 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

To study the protective effect of suture parathyroid marker method on the function of parathyroid gland in thyroid cancer surgery

Read the detailed description

This is a prospective randomized controlled study.In the experimental group, the suture parathyroid marker method was used to mark the parathyroid gland at the first time when it shows, and this marker was further used to identify and locating the inferior parathyroid marker in subsequent central region dissection. In the control group, the central area was routinely cleaned without suture parathyroid marker .

02

Conditions studied

  • Thyroid Cancer
  • Hypoparathyroidism
  • Marker; Structural
  • Complication of Surgical Procedure
  • Parathyroid Function Low Adverse Event

Keywords

  • Thyroid Cancer
  • Hypoparathyroidism
  • parathyroid marker
03

In context

Thyroid Neoplasms

785 studies on the registry are indexed under Thyroid Neoplasms; 204 are open to participants now.

This study's planned enrollment of 400 is above the median of 53 across 520 interventional studies indexed under Thyroid Neoplasms.

Browse Thyroid Neoplasms studies →

Lead sponsor

Bo Wang,MD is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with thyroid cancer who need central compartment dissection
  • Routine neck incision surgery
  • Patients undergoing primary neck surgery

Exclusion criteria

Exclusion Criteria:

  • Benign thyroid tumor patients
  • Selecting patients with endoscopes, small incisions, or robotic surgery
  • Patients with hyperparathyroidism
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
400 participants (estimated)

Study arms

  • No intervention
    Control group

    Routine thyroidectomy and central lymph node dissection

  • Experimental
    Parathyroid marker group

    When the lower parathyroid gland is first seen, the parathyroid gland is sutured with a suture during the operation, and then during this subsequent cleaning, rapid parathyroid localization and parathyroid glands are performed through this marker.

    Procedure: The suture marks the location of the parathyroid gland

Interventions

  • ProcedureThe suture marks the location of the parathyroid gland

    When the lower parathyroid gland is first seen, the parathyroid gland is sutured with a suture during the operation, and then during this subsequent cleaning, rapid parathyroid localization and parathyroid glands are performed through this marker. Vascular protection.

06

What researchers measure

Primary outcomes

  1. The stitch marking operation time

    The time required for making a parathyroid marker by a suture method

    Time frame: During surgery

  2. Specimen inspection time

    The time required for finding parathyroid glands in surgical specimens

    Time frame: During surgery

  3. The number of transplanted parathyroid glands

    The number of parathyroid glands required for autotransplantation of parathyroid glands

    Time frame: When the surgery is completed

  4. Parathyroid hormone level testing

    Parathyroid hormone levels before and after surgery

    Time frame: 0 days, 1 day, 2 weeks after surgery

  5. Calcium levels

    Calcium level before and after surgery to detect

    Time frame: 0 days, 1 day, 2 weeks after surgery

07

Study locations

1 of 1 sites recruiting
  • Fujian Medical University Union Hospital
    FuZhou, Fujian 350001, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 2, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03514251
Lead sponsor
Bo Wang,MD
Responsible party
Bo Wang,MD (Clinical Professor, Fujian Medical University) — Sponsor-investigator
First posted
May 2, 2018
Start date
Apr 1, 2018
Primary completion
Sep 30, 2018 (estimated)
Completion
Sep 30, 2018 (estimated)
Last update
May 2, 2018

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion